| http://www.w3.org/ns/prov#value | - eir ability to bind to CD14 and for their inability to induce the release of proinflammatory cytokines such as IL-8 or TNF-?? from IECs.Given orally, lipoteichoic acid according to the invention can be used to maintain immune homeostasis, modulate bacterial colonisation, or target bacterially-mediated disease and infection or LTA/LPS -mediated disease not only in the gastrointestinal tract but als
|
